Skip to content
10-K

Annual Report

Celldex Therapeutics, Inc. CLDX

0001104659-26-019652

← back to feed
Filed
Feb 25, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 13, 2026 66.57M sh
Shares Diluted FY 2025 · Dec 31, 2025 66.42M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 64.4M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 48.45M sh
Capex FY 2025 · Dec 31, 2025 $2.71M
Capex FY 2025 · Dec 31, 2024 $1.92M
Capex FY 2025 · Dec 31, 2023 $1.82M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$210.95M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$157.78M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$107.29M
Cash And Equivalents FY 2025 · Dec 31, 2025 $28.87M
Cash And Equivalents FY 2025 · Dec 31, 2024 $28.36M
Stockholders Equity FY 2025 · Dec 31, 2025 $527.17M
Stockholders Equity FY 2025 · Dec 31, 2024 $747.01M
Stockholders Equity FY 2025 · Dec 31, 2023 $429.17M
Stockholders Equity FY 2025 · Dec 31, 2022 $326.2M
Current Liabilities FY 2025 · Dec 31, 2025 $50.99M
Current Liabilities FY 2025 · Dec 31, 2024 $39.5M
Total Liabilities FY 2025 · Dec 31, 2025 $55.82M
Total Liabilities FY 2025 · Dec 31, 2024 $45.34M
Current Assets FY 2025 · Dec 31, 2025 $534.66M
Current Assets FY 2025 · Dec 31, 2024 $747.16M
Total Assets FY 2025 · Dec 31, 2025 $582.98M
Total Assets FY 2025 · Dec 31, 2024 $792.34M
Eps Diluted FY 2025 · Dec 31, 2025 −$3.90
Eps Diluted FY 2025 · Dec 31, 2024 −$2.45
Eps Diluted FY 2025 · Dec 31, 2023 −$2.92
Eps Basic FY 2025 · Dec 31, 2025 −$3.90
Eps Basic FY 2025 · Dec 31, 2024 −$2.45
Eps Basic FY 2025 · Dec 31, 2023 −$2.92
Sga Expense FY 2025 · Dec 31, 2025 $43.84M
Sga Expense FY 2025 · Dec 31, 2024 $38.55M
Sga Expense FY 2025 · Dec 31, 2023 $30.91M
Rd Expense FY 2025 · Dec 31, 2025 $245.07M
Rd Expense FY 2025 · Dec 31, 2024 $163.55M
Rd Expense FY 2025 · Dec 31, 2023 $118.01M
Net Income FY 2025 · Dec 31, 2025 −$258.76M
Net Income FY 2025 · Dec 31, 2024 −$157.86M
Net Income FY 2025 · Dec 31, 2023 −$141.43M
Operating Income FY 2025 · Dec 31, 2025 −$287.37M
Operating Income FY 2025 · Dec 31, 2024 −$195.08M
Operating Income FY 2025 · Dec 31, 2023 −$154.54M
Cost Of Revenue FY 2025 · Dec 31, 2025 $200K
Cost Of Revenue FY 2025 · Dec 31, 2024 $200K
Cost Of Revenue FY 2025 · Dec 31, 2023 $300K
Revenue FY 2025 · Dec 31, 2025 $1.55M
Revenue FY 2025 · Dec 31, 2024 $7.02M
Revenue FY 2025 · Dec 31, 2023 $6.88M